Thermo Fisher Scientific (TMO) PT Raised to $715 at Cowen

Thermo Fisher Scientific (TMO) PT Raised to $715 at Citi

October 28, 2021 5:47 AM EDT

Citi analyst Patrick Donnelly raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $715.00 (from $700.00) while maintaining a Buy rating.... More

Thermo Fisher lifts annual forecast on boost from COVID-related sales

October 27, 2021 6:19 AM EDT

By Mrinalika Roy

(Reuters) -Thermo Fisher Scientific Inc on Wednesday reported better-than-expected quarterly profit and raised its full-year forecast for revenue as well as earnings, fuelled by strong COVID-19 related sales and recovery in its mainstay business.

Shares of the world's largest maker of scientific instruments rose nearly 3% to touch a record high of $625.99 after it also raised its outlook for next year.

Thermo Fisher makes and sells coronavirus tests and also provides raw materials and... More

Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.09

October 27, 2021 6:09 AM EDT

Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.76, $1.09 better than the analyst estimate of $4.67. Revenue for the quarter came in at $9.33 billion versus the consensus estimate of $8.39 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2021 EPS of $23.37, versus the consensus of... More

Thermo Fisher set to benefit from demand for testing kits, vaccines

October 26, 2021 1:22 PM EDT

By Amruta Khandekar and Mrinalika Roy

(Reuters) - Thermo Fisher Scientific Inc's third-quarter profit is likely to get a boost from a rebound in COVID-19 testing due to the highly contagious Delta variant and sustained demand for vaccines against the coronavirus, Wall Street analysts said.

In July, when cases eased in the United States, the company cut its annual sales forecast for COVID-19 tests by $900 million. But the demand has again picked up pace in recent months amid a surge in Delta-led infections.

The world's largest maker of scientific instruments, which also supplies raw materials for COVID-19... More